Beta-Hinweis: Alle Case Studies zeigen Demonstrations-Loops. Keine Rechtsberatung.

Patent-Prosecution-Library.
Ehrliche Verdicts.

Jeder Loop zeigt ClaimForge's autonomen Prosecution-Workflow von der OA-Analyse bis zum Re-Search — mit allen Zwischenschritten, Amendments und Limits.

Try free OA analysis → Apply to Pilot Program ClaimForge vs manual
Jurisdiktion:
Tech:
ML-Based Cache Eviction: USPTO §103 Obviousness Loop
Refine
USPTO Software / ML 35 U.S.C. §103
Obviousness-Rejection (Multi-Reference) — Feedback-Loop-Architektur als Unterscheidungsmerkmal
Patentanwalts-Niveau. Obviousness-Rejection ueber zwei Referenzen. ClaimForge schlaegt Feedback-Loop-Architektur vor — kein Referenz-Dokument offenbart das.
Loop ansehen →
Self-Locking Fastener: EPO Art. 56 Inventive Step Loop
Pass
EPO Mechanik Art. 56 EPC
Inventive Step Objection — Bulk Locking Ratio + Non-Uniform Density
Patentanwalts-Niveau. PSA-Analyse + nicht-uniforme Dichteverteilung. EPO-BoA-Referenz T 1056/14 als Rahmenwerk.
Loop ansehen →
CRISPR-Cas9: EPO Art. 54 Novelty Loop
Refine
EPO Biotech / Life Sciences Art. 54 EPC
Novelty Objection (First-to-File) — Sequenz- und Guide-RNA-Amendments
Patentanwalts-Niveau. Neuheitsschaden ueber fruehere Offenbarung. Sequenz-, Prioritaets- und Guide-RNA-Amendments.
Loop ansehen →
Dynamische Cache-Allokation: EPO Art. 83 Insufficient Disclosure Loop
Refine
EPO Software / ML Art. 83 EPC
Insufficient Disclosure — Working-Set-Size-Parameter ohne Messmethode offenbart
Patentanwalts-Niveau. Art. 83 Einwand — Messmethode fehlt. Agent ergänzt Sliding-Window-Definition, Re-Search deckt D1-Überlappungsrisiko auf.
Loop ansehen →
Bioimpedance Sensor: EPO Art. 123(2) Added Subject Matter Loop
Pass
EPO Medizintechnik Art. 123(2) EPC
Added Subject Matter — Adaptive Frequency Sweep aus spezifischer Kombination isoliert (Intermediate Generalization)
Patentanwalts-Niveau. Art. 123(2) Einwand — ursprungliche Kombination wiederhergestellt (Adaptive Freq + Elektrodenpaar 7+8 + Vorverstarker Fig. 3) mit G 2/10-Rahmenwerk.
Loop ansehen →
CRISPR-Cas9: EPO Art. 54 Novelty Loop
Refine
EPO Biotech / Life Sciences Art. 54 EPC
Novelty Objection (First-to-File) — Sequenz- und Guide-RNA-Amendments
Patentanwalts-Niveau. Neuheitsschaden ueber fruehere Offenbarung. Sequenz-, Prioritaets- und Guide-RNA-Amendments.
Loop ansehen →
5 Ways to Escape a Novelty Rejection — CRISPR Art. 54 Strategies
Guide
EPO Biotech / Life Sciences Art. 54(2) EPC
Novelty Escape — Ortholog Substitution, Delivery Limitation, HDR Pathway, Indication, Method-of-Treatment
Five proven Art. 54(2) amendment strategies from the CRISPR-Cas9 case study, mapped to ClaimForge's pipeline — claim language, escape logic, and confidence scores for each.
Loop ansehen →
CRISPR Patent Novelty Landscape: Broad, Intellia, Caribou, Editas
Guide
EPO Biotech / Life Sciences Art. 54 EPC / 35 U.S.C. §102
Novelty Landscape — 4 CRISPR-Patente, 4 Amendment-Workflows
Landscape-Seite ueber Broad/CVC, Intellia LNP-Hepatitis-B-Therapie, Caribou chRDNA, Editas SaCas9 — jeweils mit Vorher/Nachher-Claim-Strukturen, gemappt auf ClaimForge-Workflow.
Loop ansehen →
AI Prior-Art Search & Sequence-Similarity Novelty: mAb, AAV, mRNA, Protein-Engineering
Guide
USPTO Biotech / Life Sciences Art. 54 EPC / 35 U.S.C. §102
Novelty Landscape — 4 Biotech-Patente, 4 Sequence-Similarity-Workflows
AI-gestuetzte Prior-Art-Recherche und Sequence-Similarity-Novelty ueber CDR-Grafting (Biogen), AAV-Capsid-Engineering (Voyager), mRNA-Codon-Optimierung (Moderna/BioNTech), generative Protein-Engineering-Biophysical-Window-Constraints (Generate Biomedicines) — Espacenet + Google Patents-Recherche, BLAST-Style-Alignment-Scoring, jeweils mit Vorher/Nachher-Claim-Strukturen.
Loop ansehen →
AI Prior-Art Search & Sequence-Similarity Novelty: mAb, AAV, mRNA, Protein-Engineering
Guide
USPTO Biotech / Life Sciences Art. 54 EPC / 35 U.S.C. §102
Novelty Landscape — 4 Biotech-Patente, 4 Sequence-Similarity-Workflows
AI-gestuetzte Prior-Art-Recherche und Sequence-Similarity-Novelty ueber CDR-Grafting (Biogen), AAV-Capsid-Engineering (Voyager), mRNA-Codon-Optimierung (Moderna/BioNTech), generative Protein-Engineering-Biophysical-Window-Constraints (Generate Biomedicines) — Espacenet + Google Patents-Recherche, BLAST-Style-Alignment-Scoring, jeweils mit Vorher/Nachher-Claim-Strukturen.
Loop ansehen →
AI-Assisted Prior-Art Ranking for Software-Implemented Invention: USPTO §103 Loop
Refine
USPTO Software / ML 35 U.S.C. §103
Obviousness Loop — Embedding Prior-Art Ranking + Citation Graph Pruning + Amendment Drafting
Four software-implemented patent families (ML cache eviction, distributed-ledger sharding, streaming event deduplication, federated-learning DP budget) ranked and re-ranked through ClaimForge's AI retrieval pipeline. 35 U.S.C. §103 obviousness objections surfaced; amendment strategies combine citation-graph pruning with semantic novelty scoring.
Loop ansehen →
ClaimForge vs manual → Try free OA analysis → Apply to Pilot program →